How is mass spectrometry advancing drug discovery?

<p class="MsoNormal"><span style= "mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;">Today’s episode is titled, “How is mass spectrometry advancing drug discovery?", which covers two articles written for Volume 23, Issue 3 – Summer 2022 of DDW. They are called “Native mass spectrometry: Drug discovery’s new kid on the block”, and “Addressing the developability gap in pharma”.</span></p> <p class="MsoNormal"><span style= "mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;">In the first article, you will hear from Id-leer Liko, klee-tos Sokratous & Miguel Silva at OMass Therapeutics.</span></p> <p class="MsoNormal"><span style= "mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;">In the second article, you will hear from Susan Darling, Senior Director, CE and Biopharma, SCIEX and Todd Stawicki, Senior Global Marketing Manager, Biopharma, SCIEX.</span></p>